Clearstead Trust’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.24K Buy
41
+32
+356% +$2.72K ﹤0.01% 849
2026
Q1
$776 Sell
9
-20
-69% -$1.79K ﹤0.01% 947
2025
Q4
$2.53K Buy
+29
New +$2.2K ﹤0.01% 870
2023
Q4
Sell
-131
Closed -$6.5K 437
2023
Q3
$6.5K Buy
+131
New +$7.33K ﹤0.01% 372

Other funds holding GMED

Clearstead Trust's GMED Position: Q2 2026 in Review

Clearstead Trust increased its Globus Medical (GMED) stake by 356% in Q2 2026, buying an estimated $2.72K and bringing the position to 41 shares worth $3.24K. The position accounts for ﹤0.01% of the portfolio, ranked #849.

Clearstead Trust first reported a position in GMED in Q3 2023 and has held it in 4 quarters since. The position peaked at $6.5K in Q3 2023. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Clearstead Trust held 41 shares of Globus Medical worth $3.24K as of Q2 2026.
  • Clearstead Trust bought 32 Globus Medical shares in Q2 2026, an estimated $2.72K.
  • Globus Medical made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #849 holding.
  • Clearstead Trust first reported a position in Globus Medical in Q3 2023 and has held it in 4 quarters since.
  • Clearstead Trust's Globus Medical position peaked at $6.5K in Q3 2023.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.